Literature DB >> 9686407

Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.

L Toll1, I P Berzetei-Gurske, W E Polgar, S R Brandt, I D Adapa, L Rodriguez, R W Schwartz, D Haggart, A O'Brien, A White, J M Kennedy, K Craymer, L Farrington, J S Auh.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9686407

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN： 1046-9516


× No keyword cloud information.
  99 in total

Review 1.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

2.  The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward.

Authors:  Taline V Khroyan; Willma E Polgar; Gerta Cami-Kobeci; Stephen M Husbands; Nurulain T Zaveri; Lawrence Toll
Journal:  J Pharmacol Exp Ther       Date:  2010-12-21       Impact factor: 4.030

3.  {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.

Authors:  L Toll; L Jimenez; N Waleh; K Jozwiak; A Y-H Woo; R-P Xiao; M Bernier; I W Wainer
Journal:  J Pharmacol Exp Ther       Date:  2010-11-11       Impact factor: 4.030

4.  Photoactivatable neuropeptides for spatiotemporally precise delivery of opioids in neural tissue.

Authors:  Matthew R Banghart; Bernardo L Sabatini
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

5.  Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.

Authors:  Andrew C Eschenroeder; Allison A Vestal-Laborde; Emilse S Sanchez; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2011-10-14       Impact factor: 7.452

Review 6.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

7.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

8.  Quantitative comparison of functional screening by measuring intracellular Ca2+ with radioligand binding at recombinant human dopamine receptors.

Authors:  Matthias U Kassack
Journal:  AAPS PharmSci       Date:  2002

9.  The design and synthesis of a novel quinolizidine template for potent opioid and opioid receptor-like (ORL1, NOP) receptor ligands.

Authors:  Ling Jong; Nurulain Zaveri; Lawrence Toll
Journal:  Bioorg Med Chem Lett       Date:  2004-01-05       Impact factor: 2.823

10.  Constitutively active 5-HT2/α1 receptors facilitate muscle spasms after human spinal cord injury.

Authors:  Jessica M D'Amico; Katherine C Murray; Yaqing Li; K Ming Chan; Mark G Finlay; David J Bennett; Monica A Gorassini
Journal:  J Neurophysiol       Date:  2012-12-05       Impact factor: 2.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.